SEC Form 4 · accession 0001209191-19-014100
bluebird bio, Inc. · BLUE
Statement of changes in beneficial ownership, as filed. Original on EDGAR ↗
Reporting owner
Kory James Wentworth
Officer — Principal Accounting Officer
Period of report
Feb 25, 2019
Accepted (ET)
Feb 27, 2019 · 4:57 pm EST
Rule 10b5-1 plan
unknown — predates the checkbox
Issuer CIK
0001293971
Table I — non-derivative securities
| Security | Date | Code | Shares | Price | A/D | Owned after | D/I | Nature of ownership |
|---|---|---|---|---|---|---|---|---|
| Common StockF2 | Feb 25, 2019 | S | 208 | $150.0038 | D | 6,746 | D |
Table II — derivative securities
No Table II lines on this filing.
Explanation of responses
- F1The sales reported in this Form 4 were effected pursuant to a 10b5-1 trading plan adopted by the reporting person on December 19, 2018.
- F2The range in prices for the transaction reported on this line was $150.00 to $150.10. The average weighted price was $150.0038. The reporting person will provide, upon request by the SEC, the issuer or security holder of the issuer, full information regarding the number of shares sold at each separate price.